Celgene Corp (NASDAQ:CELG)

110.55
Delayed Data
As of May 01
 +2.49 / +2.30%
Today’s Change
71.32
Today|||52-Week Range
129.06
-1.17%
Year-to-Date

Today’s Trading

Previous close108.06
Today’s open108.06
Day’s range108.02 - 112.00
Volume6,594,911
Average volume (3 months)5,639,245
Market cap$87.7B
Dividend yield--
Data as of 4:00pm ET, 05/01/2015

Growth & Valuation

Earnings growth (last year)+41.84%
Earnings growth (this year)+28.67%
Earnings growth (next 5 years)+23.60%
Revenue growth (last year)+17.89%
P/E ratio46.2
Price/Sales11.75
Price/Book13.56

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.60-0.88%
LLYEli Lilly and Co+1.25+1.74%
VRXValeant Pharmaceutic...+6.09+2.81%
ABBVAbbVie-0.34-0.53%
Data as of 4:02pm ET, 05/01/2015

Financials

Last reporting dateApril 30, 2015
EPS forecast (this quarter)$1.06
Annual revenue (last year)$7.6B
Annual profit (last year)$2.0B
Net profit margin26.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers